Correlation Between Pfizer and MetLife

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and MetLife at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and MetLife into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and MetLife, you can compare the effects of market volatilities on Pfizer and MetLife and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of MetLife. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and MetLife.

Diversification Opportunities for Pfizer and MetLife

-0.41
  Correlation Coefficient

Very good diversification

The 3 months correlation between Pfizer and MetLife is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and MetLife in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MetLife and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with MetLife. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MetLife has no effect on the direction of Pfizer i.e., Pfizer and MetLife go up and down completely randomly.

Pair Corralation between Pfizer and MetLife

Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the MetLife. But the stock apears to be less risky and, when comparing its historical volatility, Pfizer Inc is 1.02 times less risky than MetLife. The stock trades about -0.01 of its potential returns per unit of risk. The MetLife is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  7,012  in MetLife on September 3, 2024 and sell it today you would earn a total of  1,811  from holding MetLife or generate 25.83% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Pfizer Inc  vs.  MetLife

 Performance 
       Timeline  
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Pfizer is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.
MetLife 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in MetLife are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady technical and fundamental indicators, MetLife unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pfizer and MetLife Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and MetLife

The main advantage of trading using opposite Pfizer and MetLife positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, MetLife can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MetLife will offset losses from the drop in MetLife's long position.
The idea behind Pfizer Inc and MetLife pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Other Complementary Tools

Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum